Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04889794 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 22, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 2022 to Jul 2025
    • Study completion date: Aug 2023 to Dec 2026
    v4
  2. Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Primary completion date: Apr 2022 to Dec 2022
    • Study completion date: Aug 2022 to Aug 2023
    • Start date changed from estimate of Sep 1, 2021 to Sep 27, 2021
    • Site details revised at 2 of 2 sites
  3. Start date: Jun 2021 to Sep 1, 2021
    • Secondary endpoints: details revised at 1 of 1 entry
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The model of care tested in the GPS project aims to optimize pharmacotherapy for seniors undergoing cognitive assessment or suffering from major neurocognitive disorder (MCND) at home. The goal is to reduce polymedication, inappropriate medications and the treatment burden of seniors and to maintain their cognitive health, quality of life and autonomy. The intervention will include knowledge exchange sessions with nurses, pharmacists, and doctors in FMGs, and increased collaboration between these professionals and home care services teams. Other goal is to increase the satisfaction of the seniors, their families, and the professionals involved in the GPS project.
Trial Details
NCT Number NCT04889794
Lead Sponsor CHU de Quebec-Universite Laval
Collaborators: CISSS de Chaudière-Appalaches, Ciusss de L'Est de l'Île de Montréal, Fonds de la Recherche en Santé du Québec
Conditions
(from sponsor)		 Major Neurocognitive Disorder
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov